Cyteir Therapeutics' Grant

Cyteir Therapeutics raised a round of funding on June 29, 2016. Investors include National Cancer Institute.

Cyteir Therapeutics is a research-stage biopharmaceutical company leveraging its expertise in DNA repair and genome instability to develop new targeted therapeutics for a range of human diseases, incl…

Articles about Cyteir Therapeutics' Grant: